The largest community of pharma leaders

Rallybio Expands Drug Development Team with Addition of Ann Willauer, PMP

FARMINGTON, Conn.–(BUSINESS WIRE)–#Rallybio–Rallybio LLC, a development-stage biotechnology company, today announced that it has further expanded its drug development capabilities with the addition of Ann Willauer, PMP. Ms. Willauer, who is highly experienced in scientific, project and portfolio management, will help advance Rallybio’s mission to identify and accelerate the development of transformative breakthrough therapies for patients with severe and rare disorders. “As we build our portfolio of….

Recent Articles